Scarica l'app Stockscreener
14.52
6.92%
-1.08
Dopo l'orario di chiusura:
14.55
0.03
+0.21%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HIMS Giù?
Forum
Previsione
Hims Hers Health Inc Borsa (HIMS) Ultime notizie
10 Health Care Stocks Whale Activity In Today's Session - Benzinga
Hims & Hers at the Crossroads: Navigating the ‘Regulatory Winter’ of 2026 - FinancialContent
The Complicated Legal Battle Between Novo Nordisk and Hims & Hers - The Fashion Law
Hims & Hers stock steadies in premarket as Citi cuts target, SEC probe keeps GLP-1 risks in play - TechStock²
Hims & Hers: The Telehealth Growth Story Younger Investors Can't Afford to Ignore - Yahoo Finance
Hims & Hers: The Telehealth Growth Story Younger Investors Can't Afford to Ignore - The Motley Fool
The Law Offices of Frank R. Cruz Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of Investors - The AI Journal
Hims & Hers Posts Robust Growth Boosted by New Acquisition - timothysykes.com
HIMS vs. AMWL: Which Telehealth Stock Is the Better Investment Now? - The Globe and Mail
Barclays Lowers Price Target for HIMS to $25, Maintains Overweig - GuruFocus
Morgan Stanley Lowers Price Target for HIMS to $21 | HIMS Stock News - GuruFocus
Hims & Hers Health: The GLP-1 Party Is Over (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health, Inc. (NYSE:HIMS) Q4 2025 Earnings Call Transcript - Insider Monkey
Discipline and Rules-Based Execution in HIMS Response - Stock Traders Daily
Hims And Hers Balances GLP 1 Scrutiny With Eucalyptus Expansion Plans - Yahoo Finance
Regulatory Scrutiny of Compounded Drugs Puts Hims & Hers’ Growth, Partnerships, and Liability Risk in the Spotlight - TipRanks
Bronstein, Gewirtz & Grossman, LLC Is Investigating Hims & Hers Health, Inc. (HIMS) And Encourages Shareholders to Connect - ACCESS Newswire
Hims & Hers Earnings Call Signals Growth Amid Risks - TipRanks
These Stocks Are Today’s Movers: AMD, Hims & Hers, Keysight, IBM, Kratos, Vir Biotechnology, Whirlpool, and More - Barron's
Earnings live: Home Depot stock climbs after earnings beat, Hims & Hers slides, Constellation Energy rises - Yahoo Finance
HIMS Analyst Rating Update: Leerink Partners Lowers Price Target - GuruFocus
Hims & Hers Health: Don't Get Lost In The Weeds (NYSE:HIMS) - Seeking Alpha
HIMS: Analyst TD Cowen Lowers Price Target to $17.00 | HIMS Stoc - GuruFocus
Hims & Hers Health: Great Vision, Now On Sale -- Here's Why I'm Upgrading (NYSE:HIMS) - Seeking Alpha
HIMS Analyst Rating Update: Citigroup Lowers Price Target | HIMS Stock News - GuruFocus
Hims & Hers Stock Faces Heavy Sell-Off Amid SEC Probe Into GLP-1 Disclosures - GuruFocus
HIMS Stock Plummets After Wall Street Downgrade, Price Target Cuts Following 'Disappointing' Q4 Report - Stocktwits
HIMS: BTIG Downgrades Hims & Hers Health to Neutral | HIMS Stock News - GuruFocus
Jefferies holds Hims and Hers stock rating at Hold on guidance concerns - Investing.com Nigeria
Hims & Hers Health Analysts Cut Their Forecasts After Q4 Results - Benzinga
Hims & Hers Stock Slips Despite Q4 Earnings Beat, Margins Contract - Yahoo Finance
AMD, Hims & Hers, Keysight, Novo Nordisk, IBM, Kratos, Vir, and More Movers - Barron's
Truist Securities Reiterates Hold Rating on HIMS, Lowers Price T - GuruFocus
Truist cuts Hims and Hers stock price target on quarterly ramp concerns - Investing.com India
Evercore ISI Group Lowers Price Target for Hims & Hers Health (H - GuruFocus
Hims & Hers Health (HIMS) Stock Plunges 7-9% to Near $14 After Soft Q1 2026 Guidance Despite Q4 Beat - International Business Times Australia
Hims & Hers Faces Investor Scrutiny Amid Regulatory and Growth Challenges - AD HOC NEWS
Hims & Hers Health (NYSE:HIMS) Trading Down 6.3% After Analyst Downgrade - MarketBeat
Biggest stock movers Tuesday: HIMS, VIR, CLVT, and more - Seeking Alpha
Hims & Hers Stock Drops. Why Earnings Are Underwhelming Investors. - Barron's
AMD, Hims & Hers, Home Depot, Kratos, Novo Nordisk, IBM, Keysight, Vir Biotechnology, and More Movers - Barron's
Meta, AMD announce chip partnership, Novo Nordisk cuts US GLP-1 prices - Yahoo Finance
KeyBanc maintains Hims and Hers stock rating on revenue outlook - Investing.com
Hims & Hers Health Stock (HIMS) Opinions on Q4 Earnings Release - Quiver Quantitative
Novo Nordisk: Investors Focusing On CagriSema Results Are Missing The Big Picture (NVO) - Seeking Alpha
Hims & Hers Health After The GLP-1 Collapse - Seeking Alpha
Hims & Hers Stock StumblesCautions About Pressure Due To Super Bowl Ad, Change In Shipping Cadences - Benzinga
Hims & Hers Health, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Hims & Hers Health (NYSE:HIMS) Cut to "Neutral" at BTIG Research - MarketBeat
Earnings live: Hims & Hers stock slides, Domino's rises as investors await crucial update from Nvidia - Yahoo Finance
AMD, Home Depot, Novo Nordisk, Hims & Hers, Keysight, Vir Biotechnology, and More Movers - Barron's
Deutsche Bank Adjusts Hims & Hers Health Price Target to $25 From $31, Maintains Hold Rating - marketscreener.com
Home Depot, Novo Nordisk, Hims & Hers, IBM, BWX, and More Stock Market Movers - Barron's
Hims Expands Globally, Guides Higher - GuruFocus
Truist Securities Adjusts PT on Hims & Hers Health to $18 From $37, Maintains Hold Rating - marketscreener.com
Evercore ISI cuts Hims and Hers stock price target on growth concerns - Investing.com
Hims & Hers Snaps EPS Losing Streak but Shares Still in Free Fall - Yahoo Finance
Hims & Hers Q4 Earnings Show Growth Amid GLP-1 Scrutiny (NYSE:HIMS) - Seeking Alpha
Hims & Hers Falls on Soft Q1 Revenue Guidance - GuruFocus
BofA cuts Hims and Hers stock price target on revenue concerns - Investing.com UK
Hims & Hers, IBM, BWX, Kratos, Vir, Home Depot, and More Stock Market Movers - Barron's
Hims & Hers Health (HIMS) Faces SEC Investigation, Stock Declines - GuruFocus
1.37%
0.80%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):